Fingerprint Dive into the research topics of 'A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer'. Together they form a unique fingerprint.